Top Abstract Purchase Related
Home
>
Node
>
Subnode

Highly recommended dose of MK4 for osteoporosis

Bunyaratavej, N.; Kittimanon, N.; Jitivirai, T.; Tongthongthip, B.

Journal of the Medical Association of Thailand 92 Suppl 5: S4-S6

2009

ISSN/ISBN: 0125-2208
PMID: 19894328
Document Number: 12907
The recommended dose of Menatretenone is 45 mg three times a day; however the compliant in daily practice is not convenient. This study shows the twice dose per day is inferior to the recommended dose. This study used the level of Gla protein in osteocalcin as a parameter for the comparison. The mean of three-time dose a day is 11.27 nanogram per milliliter while the mean of the other group is 6.07 nanogram per milliliter after the three-month treatment.

Document emailed within 1 workday
Secure & encrypted payments

Bunyaratavej, N. 2011: Recommended dose of alfacacidol for osteoporosis Journal of the Medical Association of Thailand 94 Suppl. 5: S7-S9
Walsh, M.N. 2000: In an article last summer, you mentioned that a 0.3 milligram daily dose of estrogen is effective in preventing osteoporosis. Is a dose that low also effective for preventing heart disease? Health News 6(3): 10
Grecomoro, G.; Martorana, U.; Muscolino, A. 1983: Our experience on the use of low-dose calcitonin in osteoporosis La Clinica Terapeutica 107(4): 297-303
2005: Menostar: a low-dose estrogen patch for osteoporosis Obstetrics and Gynecology 105(2): 432-433
Heidelmann, G. 1979: Problems of high-dose sodium fluoride therapy in osteoporosis. 3. Practice of osteoporosis therapy with sodium fluoride Zeitschrift für Arztliche Fortbildung 73(12): 581-584
Kruszewski, J.; Kłos, K.; Sułek, K. 2006: Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 21(125): 443-448
Hashizume, T.; Tomiyasu, S.; Yomiya, K.; Yoshimoto, T.; Harada, A.; Matoba, M. 2007: Validity of recommended minimum dose of prior morphine to initiate transdermal fentanyl patch in prescribing information - multicenter survey of on prescriptions by palliative care specialists in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(6): 897-902
Aksaranugraha, S. 2015: BMD Changes Following 2-Year Treatment of Osteoporosis by using BMK to Monitor the Dose of Bisphosphonates Journal of the Medical Association of Thailand 98 Suppl. 8: S8-12
Takahashi, T.; Saikawa, Y.; Yoshida, M.; Kitagawa, Y.; Otani, Y.; Kubota, T.; Kumai, K.; Kitajima, M. 2006: A pilot study of combination chemotherapy with S-1 and low-dose cisplatin for highly advanced gastric cancer Anticancer Research 26(2b): 1631-1635
Aksaranugraha, S. 2011: Observation: application and advantages of BMK in osteoporosis by monitoring the dose of antiresorptive drugs with CTx Journal of the Medical Association of Thailand 94(Suppl 5): S63-S70
Heidelmann, G. 1979: Problems of high dose sodium fluoride treatment in osteoporosis. 2. the effect of fluorides on the human skeleton Zeitschrift für Arztliche Fortbildung 73(11): 526-529
Sambrook, P.; Raj, A.; Hunter, D.; Naganathan, V.; Mason, R.; Robinson, B. 2001: Osteoporosis with low dose corticosteroids: contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry Journal of Rheumatology 28(5): 1063-1067
Colpaert, F.C.; Janssen, P.A. 1982: Factors regulating drug cue sensitivity: the effects of dose ratio and absolute dose level in the case of fentanyl dose-dose discrimination Archives Internationales de Pharmacodynamie et de Therapie 258(2): 283-299
Pongchaiyakul, C.; Wanothayaroj, E. 2007: Performance of the Khon Kaen Osteoporosis Study (KKOS) score for identifying osteoporosis in men Journal of the Medical Association of Thailand 90(8): 1518-1523
Robin, J.C.; Ambrus, J.L. 1982: Studies on osteoporosis VI. Effect of human and salmon calcitonin on experimental osteoporosis Research Communications in Chemical Pathology and Pharmacology 35(3): 491-498
Robin, J.C.; Sirianni, S.R.; Pragay, D.A.; Ambrus, J.L. 1981: Studies on osteoporosis. V. Comparison of methods of evaluation of osteoporosis and study of chromosome changes induced by neutron activation Journal of Medicine 12(4): 251-256
Zhang, X.; Lin, J.; Yang, X.; Fei, Q.; Wang, B.; Yang, Y.; Li, J.; Ma, Z.; Zhao, F.; Wang, Q. 2015: Investigation of osteoporosis prevalence and osteoporosis-related clinical risk factors among healthy elderly male Zhonghua Yi Xue Za Zhi 95(41): 3366-3369
Suzuki, Y.; Wakabayashi, T. 2015: Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis Clinical Calcium 25(12): 1825-1834
Joseph, P.; Hughes, D. 1997: Osteoporosis. Guidelines for general practitioners. Osteoporosis Australia Australian Family Physician 26(10): 1181-5 1188-91 1194-6
Spencer, H.; Kramer, L. 1986: NIH Consensus Conference: osteoporosis. Factors contributing to osteoporosis Journal of Nutrition 116(2): 316-319